AAAAAA

   
Results: 1-9 |
Results: 9

Authors: NIEUWINT AWM OSSENKOPPELE G HEINS YM VANDERGROEP P MADAN K
Citation: Awm. Nieuwint et al., IDENTIFICATION OF 4 COMPLEX VARIANTS OF LEUKEMIA SPECIFIC TRANSLOCATIONS BY FISH, Cytogenetics and cell genetics, 81(2), 1998, pp. 187-187

Authors: LOWENBERG B VANPUTTEN WLJ FERRANT A OSSENKOPPELE G VELLENGA E VERDONCK LF GRATWOHL A BOOGAERTS MA
Citation: B. Lowenberg et al., PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION AS AN ALTERNATIVE TOAUTOLOGOUS MARROW TRANSPLANTATION IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA, Stem cells, 15, 1997, pp. 177-180

Authors: DEKKER AW VANTVEER MB SIZOO W HAAK HL VANDERLELIE J OSSENKOPPELE G HUIJGENS PC SCHOUTEN HC SONNEVELD P WILLEMZE R VERDONCK LF VANPUTTEN WLJ LOWENBERG B
Citation: Aw. Dekker et al., INTENSIVE POSTREMISSION CHEMOTHERAPY WITHOUT MAINTENANCE THERAPY IN ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of clinical oncology, 15(2), 1997, pp. 476-482

Authors: LOWENBERG B SUCIU S ARCHIMBAUD E OSSENKOPPELE G VERHOEF GEG VELLENGA E WIJERMANS P BERNEMAN Z DEKKER AW STRYCKMANS P SCHOUTEN H JEHN U MUUS P SONNEVELD P DARDENNE M ZITTOUN R
Citation: B. Lowenberg et al., USE OF RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR DURING AND AFTER REMISSION INDUCTION CHEMOTHERAPY IN PATIENTS AGED 61 YEARS AND OLDER WITH ACUTE MYELOID-LEUKEMIA (AML) - FINAL REPORT OF AML-11, A PHASE-III RANDOMIZED STUDY OF THE LEUKEMIA COOPERATIVE GROUP OFANIZATION-FOR-THE-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC-LCG) AND THE DUTCH BELGIAN HEMATOONCOLOGY COOPERATIVE GROUP (HOVON), Blood, 90(8), 1997, pp. 2952-2961

Authors: SONNEVELD P LOWENBERG B VOSSEBELD P MALKHANDI J COVELLI A DEKKER AW OSSENKOPPELE G MILLIGAN D VERHOEF G FERRANT A YIN J GRATWOHL A KOVACSOVICS T BURNETT A
Citation: P. Sonneveld et al., DOSE-FINDING STUDY OF PSC833, A NOVEL MDR REVERSING AGENT, WITH DAUNORUBICIN AND ARA-C IN UNTREATED ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML), Blood, 90(10), 1997, pp. 2517-2517

Authors: LOWENBERG B SUCIU S ZITTOUN R OSSENKOPPELE G BOOGAERTS MA WIJERMANS P VELLENGA E BERNEMAN Z DEFFER AW SONNEVELD P STRYCKMANS P SOLBU G DARDENNE M DEWITTE T ARCHIMBAUD E
Citation: B. Lowenberg et al., GM-CSF DURING AS WELL AS AFTER INDUCTION CHEMOTHERAPY (CT) IN ELDERLYPATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) - THE EORTC-HOVON PHASE-III TRIAL (AML-11), Blood, 86(10), 1995, pp. 1719-1719

Authors: LOWENBERG B BOOGAERTS MA VELLENGA E OSSENKOPPELE G DEKKER AW VANDERLELIE J SCHOUTEN HC FOPP M GRATWOHL A FEY M GMUR J VANPUTTEN W
Citation: B. Lowenberg et al., VARIOUS MODALITIES OF USE OF GM-CSF IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML) - A HOVON-SAKK RANDOMIZED STUDY (HOVON-4A), Blood, 86(10), 1995, pp. 2035-2035

Authors: BOOGAERTS MA VANPUTTEN W FERRANT A OSSENKOPPELE G DEKKER AW VELLENGA E HAGENBEEK A WIJEMANS P FEY MJ GRATWOHL A LOWENBERG B
Citation: Ma. Boogaerts et al., SHORT AND HIGH-DOSE OF LENOGRASTIM PERMITS PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTION (PBPC) IN PATIENTS WITH AML, Blood, 86(10), 1995, pp. 3910-3910

Authors: DEKKER AW VANTVEER MB HAAK HL VANDERLELIE J OSSENKOPPELE G SCHOUTEN HC SONNEVELD P VANPUTTEN WLJ WILLEMZE R LOWENBERG B
Citation: Aw. Dekker et al., CONVENTIONAL REMISSION INDUCTION FOLLOWED BY INTENSIVE CONSOLIDATION WITHOUT MAINTENANCE THERAPY IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS FROM A PHASE-II CLINICAL-TRIAL IN 130 PATIENTS, Blood, 84(10), 1994, pp. 10000144-10000144
Risultati: 1-9 |